Sucro Ltd. (SUGR.V)
9.48
+0.51
(+5.69%)
CAD |
TSXV |
Nov 20, 15:59
Sucro Enterprise Value : 633.12M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 633.12M |
| November 18, 2026 | 633.34M |
| November 17, 2026 | 632.90M |
| November 16, 2026 | 632.90M |
| November 13, 2026 | 636.67M |
| November 12, 2026 | 636.67M |
| November 11, 2026 | 636.67M |
| November 10, 2026 | 633.34M |
| November 09, 2026 | 633.34M |
| November 06, 2026 | 633.34M |
| November 05, 2026 | 636.67M |
| November 04, 2026 | 636.78M |
| November 03, 2026 | 636.78M |
| November 02, 2026 | 636.78M |
| October 30, 2026 | 633.78M |
| October 29, 2026 | 633.34M |
| October 28, 2026 | 629.68M |
| October 27, 2026 | 632.67M |
| October 26, 2026 | 650.66M |
| October 23, 2026 | 650.66M |
| October 22, 2026 | 650.66M |
| October 21, 2026 | 650.10M |
| October 20, 2026 | 652.88M |
| October 19, 2026 | 648.66M |
| October 16, 2026 | 648.66M |
| Date | Value |
|---|---|
| October 15, 2026 | 648.44M |
| October 14, 2026 | 647.33M |
| October 13, 2026 | 646.22M |
| October 09, 2026 | 646.22M |
| October 08, 2026 | 644.66M |
| October 07, 2026 | 644.66M |
| October 06, 2026 | 644.66M |
| October 05, 2026 | 644.55M |
| October 02, 2026 | 643.44M |
| October 01, 2026 | 643.44M |
| September 30, 2026 | 641.78M |
| September 29, 2026 | 640.11M |
| September 28, 2026 | 640.11M |
| September 25, 2026 | 636.78M |
| September 24, 2026 | 636.89M |
| September 23, 2026 | 636.89M |
| September 22, 2026 | 638.89M |
| September 21, 2026 | 638.67M |
| September 18, 2026 | 636.78M |
| September 17, 2026 | 636.78M |
| September 16, 2026 | 632.34M |
| September 15, 2026 | 632.34M |
| September 14, 2026 | 634.23M |
| September 11, 2026 | 634.23M |
| September 10, 2026 | 637.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Rhelion Life Sciences Corp. | 0.6031M |
| TelyRx Holdings, Inc. | 76.43M |
| George Weston Ltd. | 68.79B |
| Loblaw Cos. Ltd. | 97.69B |
| Empire Co. Ltd. | 19.13B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 11.26M |
| Revenue (Quarterly) | 180.81M |
| Total Expenses (Quarterly) | 169.55M |
| EPS Diluted (Quarterly) | 0.465 |
| Gross Profit Margin (Quarterly) | 8.94% |
| Profit Margin (Quarterly) | 6.23% |
| Earnings Yield | 24.59% |
| Operating Earnings Yield | 7.29% |
| Normalized Earnings Yield | 6.521 |